Insider Transactions in Q4 2020 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2020
|
Stefan K.F. Schwabe Executive Vice President & CMO |
SELL
Open market or private sale
|
Direct |
46,347
-94.36%
|
$1,019,634
$22.1 P/Share
|
|
Dec 21
2020
|
Stefan K.F. Schwabe Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,347
+48.55%
|
$556,164
$12.98 P/Share
|
|
Dec 14
2020
|
Stefan K.F. Schwabe Executive Vice President & CMO |
SELL
Open market or private sale
|
Direct |
53,653
-72.73%
|
$1,126,713
$21.93 P/Share
|
|
Dec 14
2020
|
Stefan K.F. Schwabe Executive Vice President & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,653
+27.37%
|
$590,183
$11.06 P/Share
|
|
Nov 09
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.11%
|
$125,000
$25.0 P/Share
|
|
Nov 09
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.18%
|
$60,000
$12.98 P/Share
|
|
Nov 05
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.11%
|
$115,000
$23.0 P/Share
|
|
Nov 05
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.18%
|
$60,000
$12.98 P/Share
|
|
Oct 15
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-25.23%
|
$300,000
$20.03 P/Share
|
|
Oct 15
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.14%
|
$180,000
$12.98 P/Share
|